Ricolinostat promotes the generation of megakaryocyte progenitors from human hematopoietic stem and progenitor cells
Open Access
- 5 February 2022
- journal article
- research article
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 13 (1) , 1-16
Abstract
Background: Ex vivo production of induced megakaryocytes (MKs) and platelets from stem cells is an alternative approach for supplying transfusible platelets. However, it is difficult to generate large numbers of MKs and platelets from hematopoietic stem cells and progenitor cells (HSPCs).Methods: To optimize the differentiation efficiency of megakaryocytic cells from HSPCs, we first employed a platelet factor 4 (PF4)-promoter reporter and high-throughput screening strategy to screen for small molecules. We also investigated the effects and possible mechanisms of candidate small molecules on megakaryocytic differentiation of human HSPCs.Results: The small molecule Ricolinostat remarkably promoted the expression of PF4-promoter reporter in the megakaryocytic cell line. Notably, Ricolinostat significantly enhanced the cell fate commitment of MK progenitors (MkPs) from cord blood HSPCs and promoted the proliferation of MkPs based on cell surface marker detection, colony-forming unit-MK assay, and quantitative real-time PCR analyses. MkPs generated from Ricolinostat-induced HSPCs differentiated into mature MKs and platelets. Mechanistically, we found that Ricolinostat enhanced MkP fate mainly by inhibiting the secretion of IL-8 and decreasing the expression of the IL-8 receptor CXCR2.Conclusion: The addition of Ricolinostat to the culture medium promoted MkP differentiation from HSPCs and enhanced the proliferation of MkPs mainly by suppressing the IL-8/CXCR2 pathway. Our results can help the development of manufacturing protocols for the efficient generation of MKs and platelets from stem cells in vitro.Keywords
Funding Information
- National Key Research and Development Program of China (2017YFA0103100, 2017YFA0103103, 2017YFA0103104)
- National Natural Science Foundation of China (81872553, 31801227)
This publication has 52 references indexed in Scilit:
- Infusion of Megakaryocytic Progenitor Products Generated from Cord Blood Hematopoietic Stem/Progenitor Cells: Results of the Phase 1 StudyPLOS ONE, 2013
- Origins of Platelet Transfusion TherapyTransfusion Medicine Reviews, 2011
- Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem CellsScience, 2010
- In Vitro Megakaryocyte Production and Platelet Biogenesis: State of the ArtTransfusion Medicine Reviews, 2010
- Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitorsBlood, 2008
- Gene expression profile of primary human CD34+CD38lo cells differentiating along the megakaryocyte lineageExperimental Hematology, 2004
- Production of functional platelets by differentiated embryonic stem (ES) cells in vitroBlood, 2003
- Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesisBlood, 2003
- Homeodomain proteins MEIS1 and PBXs regulate the lineage-specific transcription of the platelet factor 4 geneBlood, 2003
- CHEMOKINE PRODUCTION BY HUMAN MEGAKARYOCYTES DERIVED FROM CD34-POSITIVE CORD BLOOD CELLSCytokine, 1999